Eli Lilly logo

Latest headlines

Eli Lilly News

The latest Eli Lilly (LLY) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these LLY headlines next to the live Eli Lilly Fear and Greed Index.

Latest Eli Lilly Headlines60

Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally Rotates

investors.com · Jun 27, 2026

Is Eli Lilly Stock an Undervalued Healthcare Stock to Buy?

fool.com · Jun 26, 2026

Why Eli Lilly Stock Jumped to a New All-Time High Today

fool.com · Jun 26, 2026

Lilly, J&J and AbbVie Hit New Highs

gurufocus.com · Jun 26, 2026

Eli Lilly shares rise after EU panel backs expanded use of Jaypirca

proactiveinvestors.com · Jun 26, 2026

Eli Lilly (LLY) is a Top-Ranked Momentum Stock: Should You Buy?

zacks.com · Jun 26, 2026

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy

gurufocus.com · Jun 26, 2026

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy

prnewswire.com · Jun 26, 2026

Eli Lilly shares rise after EU panel backs expanded use of Jaypirca

proactiveinvestors.com · Jun 26, 2026

What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management

prnewswire.com · Jun 25, 2026

Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders

prnewswire.com · Jun 24, 2026

Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly

reuters.com · Jun 23, 2026

Trump visits Mack Trucks plant in battleground Pennsylvania district to tout economic agenda as midterms loom

foxbusiness.com · Jun 23, 2026

Biotech's Silent Resurgence (5-Year Base Breakout)

zacks.com · Jun 23, 2026

How Eli Lilly Became a $1 Trillion Company

youtube.com · Jun 23, 2026

Eli Lilly says Trump pricing policy will affect obesity drug launches in Europe

reuters.com · Jun 23, 2026

Fund manager names 3 non-AI stocks to own as Intel, AMD sink amid broader tech rout

invezz.com · Jun 23, 2026

Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock

zacks.com · Jun 23, 2026

3 Monster Stocks to Hold for the Next 10 Years

fool.com · Jun 23, 2026

Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk

fool.com · Jun 22, 2026

Eli Lilly vs Pfizer: One Owns the Obesity Market Today, The Other Paid to Compete Tomorrow

247wallst.com · Jun 22, 2026

Lilly declares third-quarter 2026 dividend

gurufocus.com · Jun 22, 2026

Lilly declares third-quarter 2026 dividend

prnewswire.com · Jun 22, 2026

13 Stocks Are Members of the $1 Trillion Club. Here's the Best Pick to Buy Right Now.

fool.com · Jun 22, 2026

Lilly's 7 Acquisitions in 3 Months: Which Will Be the Biggest Game-Changer for the Pharma Giant?

fool.com · Jun 20, 2026

3 Penny Stocks Under $5 Backed by Real Revenue Growth

marketbeat.com · Jun 20, 2026

3 Reasons to Buy Eli Lilly Stock

fool.com · Jun 20, 2026

Vertex Has a Head Start in Non-Opioid Pain. Eli Lilly Just Spent Billions to Catch Up.

fool.com · Jun 20, 2026

Prediction: Eli Lilly Will Trade at $1,200 on This Date

247wallst.com · Jun 19, 2026

Novo Nordisk Stock Rally as Owner Unveils $69 Million Obesity Research Push

gurufocus.com · Jun 19, 2026

Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know

zacks.com · Jun 18, 2026

Can Pfizer Take Share From Lilly & Novo Nordisk in the Obesity Space?

zacks.com · Jun 18, 2026

3 Stocks Doing the Heavy Lifting in Healthcare's Rebound

marketbeat.com · Jun 18, 2026

Eli Lilly Takes Another Stab at the Market for Painkillers. This Attempt Might Work.

barrons.com · Jun 16, 2026

Eli Lilly vs. Novo Nordisk: Better Obesity Drug Stock?

fool.com · Jun 16, 2026

Health Care ETFs: XLV Delivers Low Fees and Solid Returns

fool.com · Jun 16, 2026

Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL

gurufocus.com · Jun 14, 2026

Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL

prnewswire.com · Jun 14, 2026

Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting

gurufocus.com · Jun 13, 2026

Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting

prnewswire.com · Jun 13, 2026

Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know

zacks.com · Jun 12, 2026

Eli Lilly Stock Hits Buy Zone As Earnings Soar 156%. Funds Are Loading Up.

investors.com · Jun 12, 2026

Here's Why Eli Lilly (LLY) is a Strong Growth Stock

zacks.com · Jun 12, 2026

Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy

247wallst.com · Jun 12, 2026

American Express, Live Nation And A Health Care Stock: CNBC's 'Final Trades'

benzinga.com · Jun 12, 2026

Eli Lilly vs Novo Nordisk: The Battle for Obesity Drug Supremacy

247wallst.com · Jun 11, 2026

Pharma and Biotech M&A Boom Accelerates as Companies Expand Pipelines

zacks.com · Jun 11, 2026

MU, GOOGL, LLY & Other Stocks Andrew Arons is Watching This Summer

youtube.com · Jun 11, 2026

An AI Price War Is About to Break Out. You Won’t Believe Who Will Profit Most

247wallst.com · Jun 11, 2026

Healthcare ETFs: From Broad Exposure to Big Breakthroughs

etftrends.com · Jun 11, 2026

I Would Rebuild My Portfolio With Just These 3 Stocks If I Lost Everything Tomorrow

247wallst.com · Jun 10, 2026

Eli Lilly Wins FDA Nod for Extended Ebglyss Dosing in Eczema Care

zacks.com · Jun 10, 2026

Focus: Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon

reuters.com · Jun 10, 2026

Eli Lilly and Company (LLY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

seekingalpha.com · Jun 9, 2026

FDA approves Lilly's EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis

prnewswire.com · Jun 9, 2026

As Tech Stocks Slide, The Healthcare Sector Shines. Why Some Experts Say They Like This Defensive Play

investopedia.com · Jun 9, 2026

Deja Vu? AI Overspending Fears Renew

zacks.com · Jun 9, 2026

Is It Too Late To Buy The Rally In Eli Lilly Stock?

forbes.com · Jun 9, 2026

Prediction: Eli Lilly Will Trade at This Price in a Year

247wallst.com · Jun 9, 2026

Lilly Makes a New Alzheimer's Pipeline Move

gurufocus.com · Jun 9, 2026

Why Is Eli Lilly Up or Down Today?

When Eli Lilly (LLY) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a LLY move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Eli Lilly is up or down today.

How Eli Lilly News Affects the Price

News does not move the Eli Lilly (LLY) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Eli Lilly Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Eli Lilly trading volume. That is the chain to watch: headline, sentiment, volume, then the LLY price.

Trade the Eli Lilly News With Sentiment

Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Eli Lilly trading volume spike on a big story, check the Eli Lilly price history for context, follow the live LLY price, see the Eli Lilly price prediction, and read the Eli Lilly Fear and Greed Index for mood.

How do you feel about Eli Lilly?

1D

Frequently asked questions

Why is Eli Lilly up or down today?
Eli Lilly (LLY) moves on news, and the headlines above are the fastest way to see what is driving LLY today, from earnings, guidance and analyst moves to the broader market mood. Cross-check the reaction against the live Eli Lilly Fear and Greed Index and LLY trading volume.
What is the latest Eli Lilly news?
The newest Eli Lilly (LLY) headlines are listed above, most recent first, each linking to the original source. We pull the last 60 stories so you can scroll the full recent LLY news cycle in one place.
Where does Eli Lilly news come from?
We aggregate Eli Lilly (LLY) headlines from financial news wires and refresh them continuously. Each headline links straight to the original source.
How often is Eli Lilly news updated?
Continuously. The Eli Lilly (LLY) feed refreshes as new stories are published, so the headlines at the top are the freshest available.
How does Eli Lilly news relate to its Fear and Greed Index?
News drives sentiment, and sentiment drives price. A run of negative headlines tends to push the Eli Lilly Fear and Greed Index toward fear, positive coverage toward greed. Reading them together is how you separate noise from a real shift in mood.

Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.

About CFGI

The per-asset sentiment record.

CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and more than 100 individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.

Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.